ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• The Benefits Of Mobile EDC Access

  As clinical studies become increasingly decentralized, learn why study teams need to be able to monitor the influx of data in real time to ensure the integrity and success of modern trials.

• Zero Disruptions: Migrating 14 Mid-Study Clinical Trials In 16 Months

  Uncover how Imperial College London was able to effectively transfer 14 ongoing studies, encompassing over 1,700 patients and 150,000+ forms, onto a new EDC platform within 16 months.

• AI Needs A Home: Inside The Workflows That Drive Trials

  Move beyond fragmented digital tools. Learn how a governed execution layer transforms AI into a collaborator, streamlining trial decisions and creating a traceable record of human-AI insight.

• From Startup To Public Company: Scaling Finance Operations

  When basic tools no longer support your growing company, robust systems, such as ERPs, become essential for managing complex financial reporting, regulatory compliance, and multi-entity tracking.

• 3 Things To Know When Using Wearables In Your Study

  As wearables unleash new possibilities, the industry will need an effective strategy to utilize these useful tools. Consider these tips when incorporating wearables in a clinical study.

• Five Steps To Streamline Your Trial

  Explore the solution for adequately verifying and analyzing data from wearables, remote devices, and other novel data collection modalities. 

• Collecting Trial Data From Patients In Remote Areas

  Learn how mobile technology can promote trial inclusivity and diversity, and its potential to revolutionize clinical studies, making them more accessible and representative of the population.

• Why Protocol‑Driven eSource Solves Data Capture For 80% Of Sites

  Designing data capture around study protocols boosts data quality and real‑time visibility. Reducing transcription and aligning workflows helps teams improve compliance and speed decisions.

• Consolidating Access Into A Single Platform: A Site CEO's Perspective

  By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.

• AI Won't Fix Clinical Development Until Pharma Changes How They Use It

  Clinical development teams can unlock real AI value by aligning it to roles, workflows, and accountability. A practical operating model shows how to cut cycle time, reduce rework, and strengthen GxP‑ready decisions.